• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study.减瘤手术及腹腔内热灌注化疗后细菌和真菌感染的分析:一项单中心观察性研究
Int J Microbiol. 2019 Aug 1;2019:6351874. doi: 10.1155/2019/6351874. eCollection 2019.
2
Perioperative management and postoperative outcome of patients undergoing cytoreduction surgery with hyperthermic intraperitoneal chemotherapy.接受细胞减灭术联合热灌注腹腔化疗患者的围手术期管理及术后结局
Indian J Anaesth. 2019 Oct;63(10):805-813. doi: 10.4103/ija.IJA_324_19. Epub 2019 Oct 10.
3
[Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].1384例腹膜癌病患者接受细胞减灭术加腹腔内热灌注化疗的疗效
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):230-239. doi: 10.3760/cma.j.cn.441530-20201110-00603.
4
Enterocutaneous fistula in patients with peritoneal malignancy following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Incidence, management and outcomes.细胞减灭术和腹腔内热化疗后腹膜恶性肿瘤患者的肠皮肤瘘:发病率、管理及结局
Surg Oncol. 2016 Sep;25(3):315-20. doi: 10.1016/j.suronc.2016.05.025. Epub 2016 May 24.
5
Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.基于腹膜癌指数(PCI)的患者选择策略用于胃癌伴腹膜转移行完全细胞减灭术加腹腔热灌注化疗:一项单中心回顾性分析 125 例患者。
Eur J Surg Oncol. 2021 Jun;47(6):1411-1419. doi: 10.1016/j.ejso.2020.11.139. Epub 2020 Dec 1.
6
[Meta analysis of whether cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy can improve survival in patients with colorectal cancer peritoneal metastasis].[关于减瘤手术联合腹腔热灌注化疗能否改善结直肠癌腹膜转移患者生存率的Meta分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2021 Mar 25;24(3):256-263. doi: 10.3760/cma.j.cn.441530-20201111-00604.
7
Repeated cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with recurrent peritoneal carcinomatosis.复发性腹膜癌患者的重复细胞减灭术(CRS)联合腹腔热灌注化疗(HIPEC)
World J Surg Oncol. 2016 Feb 24;14(1):42. doi: 10.1186/s12957-016-0804-x.
8
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.细胞减灭术联合洛铂和多西他赛腹腔热灌注化疗可改善腹盆腔恶性肿瘤腹膜转移患者的生存情况。
World J Surg Oncol. 2016 Sep 15;14(1):246. doi: 10.1186/s12957-016-1004-4.
9
Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.结直肠癌和阑尾腺癌腹膜转移患者行完全细胞减灭术和腹腔热灌注化疗后复发部位:一项三级中心经验。
Ann Surg Oncol. 2019 Feb;26(2):482-489. doi: 10.1245/s10434-018-6860-4. Epub 2018 Dec 11.
10
Does Intraoperative Systematic Bacterial Sampling During Complete Cytoreductive Surgery (CRS) with Hyperthermic Intraoperative Peritoneal Chemotherapy (HIPEC) Influence Postoperative Treatment? A New Predictive Factor for Postoperative Abdominal Infectious Complications.在完全细胞减灭术(CRS)联合术中热灌注化疗(HIPEC)期间进行术中系统性细菌采样是否会影响术后治疗?一种术后腹部感染并发症的新预测因素。
World J Surg. 2016 Dec;40(12):3035-3043. doi: 10.1007/s00268-016-3635-6.

引用本文的文献

1
Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes.伴有腹膜转移的癌症患者接受细胞减灭术和热灌注化疗手术后面临的挑战:临床结局的全面综述
Front Surg. 2024 Dec 2;11:1498529. doi: 10.3389/fsurg.2024.1498529. eCollection 2024.
2
Emerging Status of Multidrug-Resistant Bacteria and Fungi in the Arabian Peninsula.阿拉伯半岛多重耐药细菌和真菌的新出现情况。
Biology (Basel). 2021 Nov 6;10(11):1144. doi: 10.3390/biology10111144.

本文引用的文献

1
Infectious Complications after Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy.肿瘤细胞减灭术及腹腔热灌注化疗后的感染性并发症
Surg Infect (Larchmt). 2017 Feb/Mar;18(2):157-163. doi: 10.1089/sur.2016.102. Epub 2016 Dec 1.
2
Cytoreductive surgery and HIPEC for peritoneal carcinomatosis in the elderly.老年腹膜癌的细胞减灭术和腹腔热灌注化疗
Int J Surg Oncol. 2014;2014:987475. doi: 10.1155/2014/987475.
3
Treatment of diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery and HIPEC.通过细胞减灭术和腹腔热灌注化疗治疗弥漫性恶性腹膜间皮瘤(DMPM)。
Minerva Chir. 2014 Feb;69(1):9-15.
4
The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: a comparative study.奥沙利铂或丝裂霉素 C 在结直肠癌腹膜转移 HIPEC 治疗中的应用:一项对比研究。
J Surg Oncol. 2014 May;109(6):527-32. doi: 10.1002/jso.23546. Epub 2013 Dec 28.
5
Postoperative infections after cytoreductive surgery and HIPEC for peritoneal carcinomatosis: proposal and results from a prospective protocol study of prevention, surveillance and treatment.减瘤手术及腹腔热灌注化疗治疗腹膜癌病后的术后感染:一项关于预防、监测及治疗的前瞻性方案研究的提议与结果
Eur J Surg Oncol. 2014 Aug;40(8):950-6. doi: 10.1016/j.ejso.2013.10.015. Epub 2013 Nov 4.
6
Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.细胞减灭术和腹腔热灌注化疗后的并发症和毒性。
Ann Surg Oncol. 2013 Apr;20(4):1082-7. doi: 10.1245/s10434-012-2853-x. Epub 2013 Mar 2.
7
Risk factors for recurrence following complete cytoreductive surgery and HIPEC in colorectal cancer-derived peritoneal surface malignancies.结直肠癌腹膜表面恶性肿瘤完全细胞减灭术和 HIPEC 后复发的危险因素。
Langenbecks Arch Surg. 2013 Jun;398(5):745-9. doi: 10.1007/s00423-013-1065-6. Epub 2013 Mar 1.
8
Assessment of clinical benefit and quality of life in patients undergoing cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of peritoneal metastases.评估细胞减灭术和腹腔热灌注化疗(HIPEC)治疗腹膜转移患者的临床获益和生活质量。
J Gastrointest Oncol. 2013 Mar;4(1):62-71. doi: 10.3978/j.issn.2078-6891.2012.053.
9
Complications related to hyperthermia during hypertermic intraoperative intraperitoneal chemiotherapy (HIPEC) treatment. Do they exist?高热术中腹腔内热化疗(HIPEC)治疗过程中与高热相关的并发症。它们存在吗?
Eur Rev Med Pharmacol Sci. 2012 Jun;16(6):737-42.
10
Anesthetic management in patients undergoing hyperthermic chemotherapy.行高温化疗患者的麻醉管理。
Curr Opin Anaesthesiol. 2012 Jun;25(3):348-55. doi: 10.1097/ACO.0b013e32835347b2.

减瘤手术及腹腔内热灌注化疗后细菌和真菌感染的分析:一项单中心观察性研究

Analysis of Bacterial and Fungal Infections after Cytoreduction Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Observational Single-Centre Study.

作者信息

Albukhari Talat A M, Nafady-Hego Hanaa, Elgendy Hamed, Abd Elmoneim Hanan M, Nafady Asmaa, Alzahrani Abdulaziz M

机构信息

Haematology and Immunology Department, Faculty of Medicine, Umm Alqura University, Mecca, Saudi Arabia.

Microbiology and Immunology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.

出版信息

Int J Microbiol. 2019 Aug 1;2019:6351874. doi: 10.1155/2019/6351874. eCollection 2019.

DOI:10.1155/2019/6351874
PMID:31467552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6701354/
Abstract

INTRODUCTION

While hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreduction surgery (CRS) has been shown to improve patient survival and disease-free progression in peritoneal carcinoma (PC) patients, the procedure relates to a high postoperative infection rate. Herein, we report the bacterial and fungal infections after CRS and HIPEC from a single institution in Saudi Arabia.

PATIENTS AND METHODS

A prospective observational study was conducted on 38 patients with PC selected for CRS/HIPEC procedure between 2012 and 2015 in our centre.

RESULTS

Postoperative bacterial and fungal infection within 100 days was 42.2%, bacterial infection was reported always, and fungal infection was reported in 5 (13.2%) cases. Infections from the surgical site were considered the most common infection site. Multidrug-resistant extended-spectrum beta-lactamase (ESBL) was the most frequent isolate, followed by multidrug-resistant and . Lower preoperative albumin and a prolonged preoperative activated partial thromboplastin time (APTT) are associated with postoperative infections, while a prolonged preoperative hospital stay (hazard ratio (HR) = 1.064; confidence interval (CI) = 1.002-1.112; =0.042) and more intraoperative blood loss (>10%) (HR = 3.919; 95% CI = 1.024-14.995; =0.046) were independent risk factors for postoperative infections. Three cases died during the follow-up period; all were due to infection.

DISCUSSION

The infection rate in our centre compared to previous studies of comparable patients was matching. Effective management of postoperative infections should be considered, and identified risk factors in this study can help to focus on effective prevention and treatment strategies.

摘要

引言

虽然细胞减灭术(CRS)后进行腹腔热灌注化疗(HIPEC)已显示可改善腹膜癌(PC)患者的生存率和无病进展情况,但该手术术后感染率较高。在此,我们报告沙特阿拉伯一家机构CRS和HIPEC术后的细菌和真菌感染情况。

患者与方法

对2012年至2015年期间在我们中心选择进行CRS/HIPEC手术的38例PC患者进行了一项前瞻性观察研究。

结果

100天内术后细菌和真菌感染率为42.2%,始终报告有细菌感染,5例(13.2%)报告有真菌感染。手术部位感染被认为是最常见的感染部位。多重耐药超广谱β-内酰胺酶(ESBL)是最常见的分离菌株,其次是多重耐药菌和 。术前白蛋白水平较低和术前活化部分凝血活酶时间(APTT)延长与术后感染相关,而术前住院时间延长(风险比(HR)=1.064;置信区间(CI)=1.002 - 1.112; =0.042)和术中失血量较多(>10%)(HR = 3.919;95% CI = 1.024 - 14.995; =0.046)是术后感染的独立危险因素。随访期间有3例死亡;均因感染所致。

讨论

与之前对类似患者的研究相比,我们中心的感染率相当。应考虑对术后感染进行有效管理,本研究中确定的危险因素有助于聚焦有效的预防和治疗策略。